Switch to:
More From Other Websites
Celgene: European Decision Not Best Case Scenario, Not Worst Case Either Dec 19 2014
Juno Shares Exploded Post-IPO. Should You Consider Buying Them? Dec 19 2014
Cramer's Mad Dash: Tale of two biotechs Dec 19 2014
European Panel Gives Positive Opinion on Celgene Cancer Drug Dec 19 2014
8:12 am Celgene confirms EMA CHMP adopted a positive opinion for continuous oral treatment with... Dec 19 2014
Celgene Receives Positive CHMP Opinion to Extend REVLIMID® (Lenalidomide) for Continuous Use in... Dec 19 2014
Biotech: More Upside in 2015? Dec 18 2014
Cramer: Here's what the Fed did today Dec 17 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK